Our difference: Specific, in-depth insight on payer resonating evidence
Justin Stindt Consulting is a consulting firm specializing in Strategy & Market Access advisory services for the pharmaceutical, biotech and medical device industry.
We deliver specific and actionable insight on payer resonating evidence including endpoints, how to operationalize them and the required effect size.
And we determine return on investment of different evidence generation programs, e.g. impact on access, price and forecast an investment in an additional trial delivers.
Our holistic approach integrates in-depth understanding of healthcare systems, pricing & reimbursement, health outcomes, strategic vision and business sense to provide solutions truly creating value and access.
We help Life Science companies developing and realizing a common vision of value with payer, patient and prescriber customers throughout each phase of the product lifecycle.
Early insight to focus pre-clinical efforts on areas of highest payer, patient & prescriber unmet need Early identification payer relevant endpoints and required effect size
Proof of concept (Phase I/II)
Input into phase II design to assess chances of meeting payer requirements and discharge later development risk
Payer rationalized phase III design Development of market access and pricing strategy Optimal preparation for P&R negotiations
Phase IV / post marketing
Lifecycle management : Maintain / extend access by post launch evidence generation Maintain price by tight management of prices, e.g. management of international reference pricing
Experts in Market Access
Justin Stindt Consulting offers a wide range of Value & Access Solutions
Payer advisory boards
In-depth payer & expert advice, facilitated by our experienced moderators
Specific, actionable payer insight to help you make the right decisions
Evidence generation workshops
Identifying ways to generate compelling evidence of your product’s value
Pricing and Market Access strategies
Strong value propositions leading to optimal pricing & reimbursement
Mock negotiation workshops
Optimal preparation also for the tough questions enabling you to get to a win-win
Return on investment
of different payer value propositions & evidence generation programs
Early stage assessments
Target product profiles and forecasts for early stage assets
Indication prioritization and sequencing
Prioritizing resources on most promising opportunities
Market Access training
Customized solutions for medical, commercial & market access audiences